PRESS-RELEASE ·Filed Oct 20, 2026
Press release · Earnings
Latest settled — T+1d
RCEL ▲ +0.85% at T+1d
NEUTRAL call +0.85% · α vs SPY +2.03% · entry $15.29 → $15.42
Latest observation: T+2 -6.35% FF3 residual α
T+1d
+0.85%
call +0.85% · α +2.03%
$15.42
settled 5d ago
T+5d
Pending
in 23h
T+20d
Pending
in 22d
T+60d
Pending
in 3mo
Price Chart
Loading chart...
Executive Summary
AVITA Medical announced it will report its Q3 2026 results on November 5, 2026.
Key Facts
- AVITA Medical announced it will report its Q3 2026 results on November 5, 2026.
Investment Themes
Healthcare & Medical Devices
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3384957 |
8 reports for RCEL
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 5d ago | Press Release | $15.29 | awaiting T+60 | — | $15.51 (+1.44%) |
Sep 22, 2026 4w ago | Institutional Cluster | $11.49 | awaiting T+60 | — | $15.51 (+34.99%) |
Aug 9, 2026 11w ago | Press Release | $7.60 | awaiting T+60 | — | $15.51 (+104.08%) |
Jun 11, 2026 19w ago | Institutional Cluster | $3.97 $11.20 | ▼ −182.12% | ▼ −177.72% | $15.51 (−290.68%) |
May 17, 2026 23w ago | Press Release | $4.19 | awaiting T+60 | — | $15.51 (+270.17%) |
Apr 30, 2026 25w ago | Press Release | $4.32 $4.75 | ▲ +9.95% | ▲ +6.85% | $15.51 (+259.03%) |
Apr 23, 2026 26w ago | Press Release | $4.46 $5.09 | ▲ +14.13% | ▲ +9.05% | $15.51 (+247.76%) |
Apr 14, 2026 27w ago | Press Release | $5.60 $4.41 | ▼ −21.25% | ▼ −29.77% | $15.51 (+176.96%) |
Showing 8 of 8
US Market Status
Market Closed — Opens in 20m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers